Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 4 studies | 30% ± 8% | |
naive B cell | 4 studies | 20% ± 2% | |
platelet | 4 studies | 46% ± 6% | |
dendritic cell | 4 studies | 41% ± 13% |
Insufficient scRNA-seq data for expression of TSPAN33 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1232.33 | 2638 / 2642 | 100% | 40.31 | 702 / 705 |
prostate | 100% | 957.57 | 244 / 245 | 100% | 25.33 | 501 / 502 |
kidney | 100% | 6917.11 | 89 / 89 | 99% | 102.32 | 894 / 901 |
liver | 100% | 1839.62 | 226 / 226 | 99% | 49.32 | 402 / 406 |
lung | 98% | 565.14 | 565 / 578 | 83% | 20.53 | 962 / 1155 |
intestine | 98% | 801.81 | 951 / 966 | 82% | 18.53 | 432 / 527 |
stomach | 96% | 510.77 | 346 / 359 | 84% | 18.57 | 239 / 286 |
pancreas | 100% | 1290.22 | 328 / 328 | 78% | 16.48 | 139 / 178 |
thymus | 98% | 747.50 | 637 / 653 | 80% | 23.68 | 485 / 605 |
bladder | 86% | 894.48 | 18 / 21 | 82% | 18.23 | 415 / 504 |
adrenal gland | 95% | 502.68 | 244 / 258 | 67% | 12.49 | 155 / 230 |
skin | 72% | 555.25 | 1297 / 1809 | 89% | 28.23 | 421 / 472 |
esophagus | 93% | 460.06 | 1340 / 1445 | 68% | 12.42 | 124 / 183 |
breast | 70% | 325.94 | 322 / 459 | 90% | 22.48 | 1010 / 1118 |
ovary | 49% | 214.18 | 88 / 180 | 92% | 22.21 | 395 / 430 |
uterus | 34% | 96.71 | 58 / 170 | 83% | 20.87 | 379 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 220.56 | 29 / 29 |
spleen | 100% | 2064.38 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.64 | 1 / 1 |
muscle | 99% | 691.49 | 792 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3431.08 | 914 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 551.39 | 814 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 19.28 | 40 / 45 |
adipose | 76% | 328.22 | 912 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 9.64 | 50 / 80 |
blood vessel | 57% | 230.25 | 762 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0046931 | Biological process | pore complex assembly |
GO_0051604 | Biological process | protein maturation |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005912 | Cellular component | adherens junction |
GO_0097197 | Cellular component | tetraspanin-enriched microdomain |
GO_0046930 | Cellular component | pore complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0019899 | Molecular function | enzyme binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TSPAN33 |
Protein name | Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane) |
Synonyms | PEN |
Description | FUNCTION: Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates . Plays an important role in normal erythropoiesis (By similarity). It has a role in the differentiation of erythroid progenitors (By similarity). Negatively regulates ligand-induced Notch activity probably by regulating ADAM10 activity . Mediates docking of ADAM10 to zonula adherens by interacting with ADAM10 and, in a PDZD11-dependent manner, with the zonula adherens protein PLEKHA7 . . |
Accessions | Q86UF1 ENST00000486685.3 |